Dr. Stephen Slauson is an assistant professor of pharmaceutical sciences at the University of Saint Joseph School of Pharmacy. Dr. Slauson earned a Bachelor’s degree in Chemistry and Biology from the University of Alabama. In 2009, he earned a Ph.D. in medicinal chemistry from the University of Mississippi for his work on polymer-supported sparteine derivatives as external chiral ligands under the direction of Dr. John Rimoldi. Immediately before joining the University of Saint Joseph, he worked as a postdoctoral researcher under Dr. Jeff Aubé at the University of Kansas, where he was involved in research towards the discovery of biased ligands for the kappa opioid receptor.
Dr. Slauson’s research interests reside in two overlapping areas: the treatment of drug addiction and the development of non-addictive analgesics. This research is focused on the utilization of novel chemical methods to create chemotypes with activity at kappa opioid and α4β2 nicotinic receptors. Each of these targets has demonstrated potential in both analgesia and the treatment of drug addiction.
Dr. Slauson is a member of the American Association of Colleges of Pharmacy (AACP) and the American Chemical Society (ACS). When away from work, he enjoys spending time with his family doing a variety of outdoor activities.